Analyst Ratings for VistaGen Therapeutics (VTGN)
VTGN Rating Summary
VTGN Price Target Summary
- Highest: $0.25 (Baird)
- Lowest: $0.20 (Jefferies)
- Average: $0.23
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$0.23 (-25%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
Rating Score: 2.9 / 10
Percentile Rank: 24%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/26/2022 | Maxim Group | Caroline Palomeque | Downgrade | Hold (Buy) |
N/A (N/A) |
0.18 (0.30) |
66.67% | Details |
| 7/25/2022 | Baird | Brian Skorney | Downgrade | Neutral (Outperform) |
0.25 (9.00) |
0.15 (0.30) |
100% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
